Gao et al. developed an in situ thermosensitive chitosan hydrogel containing lipid immunoregulatory factor 5 (IRF5) mRNA/CCL5 siRNA (LPR) nanoparticle complex (LPR@CHG) that reprograms an anti-tumor immune niche. The gene discussed is CCL5; the disease is neoplasm.